Healthcare
With new and groundbreaking technology constantly challenging the status quo, the healthcare industry is progressing by leaps and bounds. But in an industry built on regulations, strategic partnerships are often the key to successfully developing businesses. Our passionate advisors, backed by sub-sector teams globally, use their deep expertise in M&A, growth equity and ECM, debt advisory and corporate finance services to find your competitive edge, navigate local customs and help you create the most suitable strategy.
Contact advisor
Decopharma has been acquired by CTT
Decopharma has been acquired by CTT – Correios de Portugal, strengthening its position as a national reference in pharmaceutical logistics solutions. This strategic transaction marks an important step in the consolidation of the specialized logistics sector in Portugal, combining Decopharma’s expertise in healthcare logistics with CTT’s robust infrastructure and growth potential.
Learn moreLaboratório S. José has been acquired by SYNLAB
The private shareholders of Laboratório S. José have sold the company to SYNLAB.
Learn moreBanook, backed by Motion Equity, has acquired Fluidda
Banook Group has acquired Fluidda NV, marking a strategic expansion into advanced in-silico trials and respiratory disease modeling. Combining Banook’s expertise in cardiac safety and clinical data services with Fluidda’s AI-driven respiratory analytics creates a powerful, integrated platform. This deal strengthens Banook’s position in the contract research organization (CRO) sector, offering pharmaceutical clients broader, technology-enabled solutions to drive drug development and reduce costs.
Learn more
Jan De Backer
CEO, Fluidda NV
Read more
Celebrity-backed rehab center joins UK’s expanding addiction treatment network
DEAL FLASH: The Providence Projects, one of the UK’s leading providers of affordable private alcohol and drug rehabilitation services, has been acquired by UKAT Group, a network of rehabilitation clinics across the UK.
Learn more
Talk to our local advisor
Meet our global industry specialists
Michael Goldman
Oaklins TM Capital